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ABSTRACT 
Enteric fever is caused by Salmonella enterica serotype typhi, Salmonella paratyphi A, B, C, and Salmonella typhimurium respectively. 
Of the 2818 blood cultures reviewed, only 90 (3.2%) had positive cultures for Salmonella species while the 10,007 faecal samples cultured, 
159 (1.6%) were positive for Salmonella species. Identification of isolates was by usual bacteriological techniques including biochemical 
and serological methods. Percentage occurrence of Salmonella species in blood and faecal samples show Salmonella enterica serotype 
typhi (75.6% and 59.8%), Salmonella paratyphi A (4.4% and 9.4%), Salmonella paratyphi B (17.8% and 19.5%), Salmonella paratyphi C 
(2.2% and 6.3%) and Salmonella typhimurium (0.0% and 5.0%). The susceptibility pattern of all the isolates to the eleven drugs used as 
listed on table iii is highly revealing. For epidemiological status and proper management of patients, it is necessary that appropriate 
specimens (blood, bone marrow and faecal cultures) are examined and identification of isolates carried out as well as proper sensitivity 
testing performed prior to treatment for enteric fever. 
Keywords: Enteric fever, Blood, Faecal cultures, Salmonella species, Percentage   occurrence. 
INTRODUCTION 
Enteric fever is caused by Salmonella enterica serotype 
typhi, Salmonella paratyphi A, B, C, and Salmonella 
typhimurium respectively. Typhoid fever (infection) is 
an important global health problem with an estimated 
16 million cases and 216,000 - 600,000 or more deaths 
each year, placing typhoid fever in the range of several 
priority infectious diseases, including Human 
Papilloma Virus (HPV), rotavirus and Haemophilus 
influenza Type b (Hib). Very high rates of typhoid 
incidence were found in several DOMI (Diseases of the 
Most Impoverished) sites, providing further evidence 
that typhoid continues to be a serious problem (1). It is 
endemic worldwide but most cases occur in areas of 
Africa, Asia, and Latin America where sanitation is 
poor. Although no longer prevalent in the developed 
world, the aetiological agents continue to cause enteric 
fever in many parts of the developing world, especially 
in Asia and northern regions of Africa (2). In 2004, these 
agents were still estimated to cause approximately 22 
million cases of disease and 200,000 deaths each year, 
primarily in regions where sanitation is poor and clean 
water is inaccessible (3). 
 
Salmonella enterica serotype typhi is the aetiological 
agent of typhoid fever, a multisystem disease with 
protean manifestations and initial lesions in the bowel. 
Salmonella paratyphi A & B cause paratyphoid fever.  
 
 
Typhoid fever still remains a major public health 
problem in developing countries even in the twenty first 
century (4, 5). In Nigeria, as in other developing 
countries of the world, studies have estimated over 33 
million cases and 500,000 deaths due to typhoid fever 
per year (6). Several factors have been attributed to the 
failure of public health measures to tame the tide of the 
continuing rise in the incidence, prevalence, morbidity, 
and mortality of typhoid fever. 
 
It is customary in our society that any feverish condition 
is first treated for malaria. If this fails, then treatment for 
typhoid automatically follows and if the patient at this 
stage fails to respond, it is only then that laboratory 
investigations are remembered (7). Salmonellosis is 
responsible for a variety of clinical syndromes including 
gastroenteritis, enteric (typhoid) fever and 
extraintestinal manifestations. 
 
Typhoid fever remains one of the most prevalent acute 
infectious diseases in the developing world including 
Nigeria. It continues to exist as an endemic disease due 
to poor (improper) sanitation and low socio-economic 
status of the people (7). 
 
The clinical diagnosis of typhoid fever is considered to 
be unreliable (8). A definite diagnosis is obtained when 
the aetiologic agent, Salmonella enterica serotype typhi 
is isolated from faeces, blood, or bone marrow (9).  
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The aim of this work is to re-emphasize the need to 
properly identify aetiological agents for enteric fever in 
our region prior to treatment of same. 
MATERIALS AND METHODS 
2818 blood cultures and 10007 faecal samples at the 
Medical Microbiology Laboratory of National Hospital, 
Abuja was studied. 
Blood Culture 
The Oxoid Signal Blood Culture System (produced by 
Oxoid Limited, Wade Road, Basingstoke, Hamsphine, 
RG24 8PW, England) was used to culture samples of  
 
blood collected from patients where the condition of 




                              FIGURE I: PICTURE OF OXOID SIGNAL BLOOD CULTURE SYSTEM 
 
Collection and Processing of Blood Samples (Blood 
Culture)  
10 ml of blood collected from patient is inoculated into 
Oxoid Signal Blood Culture bottle. This is a semi-
automated system that recognizes bacterial growth in 
the blood culture by gas production. The inoculated 
bottle is placed (incubated) at 36oC (+/-) 1oC for 1 hour 
before inserting the signal device. It is continuously 
shaken for 24 hours. Incubate at 36oC (+/-) 1oC for at 
least 7 days (according to manufacturer’s instruction). 
 
A positive Oxoid blood culture bottle is indicated by 
upward movement of fluid into the signal device while 
a negative Oxoid blood culture bottle is indicated by 
absence of fluid in the signal device. 
 
All positive bottles are sub-cultured onto Chocolate 
agar, 3 Blood agar, and MacConkey agar plates and 
incubated for 24 hours at 36oC (+/-) 1oC. When 
applicable, it is re-incubated for a further 18 – 24 hours. 
The second Blood agar plate is incubated at 10% CO2  
enriched environment while the third Blood agar plate 
is incubated anaerobically (AnO2) for 48 hours. In 2000, 
it was stated that in typhoid, Salmonella enterica 
serotype typhi can be detected in the blood of 75 – 90% 
of patients during the first 10 days of infection and in 
about 30% of patients during the third week (10). 
 
Bacterial isolates were identified by Gram stain, 
biochemical reactions (KIA, urease test, citrate 
utilization test), motility test (11). Implicated bacterial 
isolates by way of the above identification methods 
were confirmed by sero-typing using Salmonella 
polyvalent O and H antisera and monovalent A, B, C, 
and D sera. The Vi sera is also available for typing 
(virulence factor). 
 
Antibiotic susceptibility (sensitivity) test using the disc 
diffusion technique is then carried out with appropriate 
drugs on confirmed Salmonella isolates. 
 
Collection and Processing of Faecal Samples 
 
3 - 10 grams of faeces collected over several days 
(usually 3 days) are preferred (12). However, we made 
use of only one sample. Faecal samples were cultured 
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on Salmonella/Shigella Agar (SSA) or Deoxycholate 
Citrate Agar (DCA) and Selanite Fluid (SF) and 
incubated at 37oC for 18 – 24 hours. The Selanite fluid 
preparation is sub-cultured on SSA or DCA and further 
incubated at 37oC for 18 – 24 hours.    
 
Salmonella and Shigella species are non lactose 
fermenters. All non lactose fermenting colonies (NLFs) 
isolated are subjected to identification as stated above 
under the blood culture methodology. Identified and 
confirmed Salmonella isolates are then subjected to 
antibiotic susceptibility test using the disc diffusion 
technique with appropriate antibiotics discs.   
 
RESULTS  
A total of 2818 blood cultures were examined, but only 
90 (3.2%) had positive cultures for Salmonella species. 
The species identified is as stated below;
TABLE I: OCCURRENCE OF SALMONELLAE SPECIES FROM BLOOD: 
Species                                                   Number of Isolates                     % Occurrence 
Salmonella enterica serotype typhi               68                                                 75.6% 
Salmonella paratyphi A                                    4                                                 4.4% 
Salmonella paratyphi B                                  16                                                 17.8% 
Salmonella paratyphi C                                    2                                                   2.2% 






FIG.II: PERCENTAGE OCCURRENCE OF SALMONELLA
SPECIES FROM BLOOD
Salmonella enterica 
serotype typhi - 75.6%                                                                
Salmonella paratyphi A -
4.4%                                                                                   
Salmonella paratyphi B -
17.8%                                                                              
 
TABLE II: OCCURRENCE OF SALMONELLAE SPECIES FROM FAECES  
Species                                             Number of Isolates                           % Occurrence 
Salmonella enteric serotype typhi                95                                                   59.8% 
Salmonella paratyphi A                                 15                                                    9.4% 
Salmonella paratyphi B                                 31                                                   19.5% 
Salmonella paratyphi C                                 10                                                     6.3% 
Salmonella typhimurium                                8                                                      5.0% 






Faecal Cultures Result 
A total of 10,007 faecal samples were cultured, but only 
159 (1.6%) had positive cultures for Salmonella species. 






Fig. iii: Percentage Occurrence of Salmonellae species 
from Faeces
Salmonella enterica 
serotype typhi - 59.8%                                                                                     
Salmonella paratyphi A -
9.4%                                                        
Salmonella paratyphi B -
19.5%                                                                                
Salmonella paratyphi C -
6.3%                                                                                       
Salmonella typhimurium -
5.0%                                                                                        
 
TABLE III: SUSCEPTIBILITY PATTERN OF SALMONELLAE SPECIES TO ALL DRUGS 
                            S. typhi            S. para A     S. para B             S. para C          S. typhimurium 
Drugs              NT   NS   %S        NT  NS  %S        NT  NS  %S      NT  NS  %S          NT  NS   %S 
Amoxycillin        63    34   54%          9     3   33.3%     20  11   55%         6    2   33.3%           1   1   100%  
Ampicillin           30     9    30%          5    2    40%        11   4   36.4%       3    1   33.3%          2    1    50% 
Augmentin         129  101  78.3%     10   6   60%          35   18  51.4%        8   6   75%            7   5   71.4% 
Cefotaxime         36  34    94.4%        7   7    100%        23   22  95.7%       3    3   100%          4    4   100%     
Ceftazidime        50   49   98%            8   8    100%       29   28   96.6%      7    7   100%          8   8    100% 
Ceftriaxone         63    60  95.2%      12   11   91.7%     30   30   100%        8    8   100%          3   3    100% 
Chloramphenicol  135  81  60%      11     6   54.5%      38   28   73.7%      8     7   87.5%         1    1   100%   
Ciprofloxacin         49     48   98%    7     7     100%        20   20  100%         5   5   100%          2    2   100%    
Cotrimoxazole       53   36   68%        9    4    44.4%      21   12   57.1%       7    4   57.1%         6   4   66.7%  
Gentamicin          63     53   84.1%     7    5     71.4%      32   24   75%          7   4   57.1%          3   3  100% 
Tetracycline          51   29   56.9%    10    4    40%         22    10   45.5%       8    5   62.5%         2   2  100% 
Note:  S. typhi = Salmonella enterica serotype typhi;                 S. para B= Salmonella paratyphi B               
S. para A= Salmonella paratyphi A;                                 S. para C= Salmonella paratyphi C 
S. typhimurium = Salmonella typhimurium 




The diagnosis and treatment of enteric fever based on 
signs and symptoms with a “positive” Widal test will 
continue to be a subject of controversy (13). In 1986, 
Edelman & Levine (8) stated that the clinical diagnosis 
of typhoid fever is considered to be unreliable. Given 
the diagnostic inadequacies of the Widal test, the use of 
blood and faecal culture is recommended when 
suspecting enteric fever (14). Moreover, modern 
medicine relies on “evidence based medical practice” 
which is embedded in the actual isolation, 
identification, and susceptibility patterns of the 
aetiologic agents from the microbiology laboratory. 
 
In 1984, Hoffman, et al., (9) stated categorically that a 
definitive diagnosis of typhoid fever is obtained when 
the aetiologic agent Salmonella enterica serotype typhi 
is isolated from faeces, blood, or bone marrow. 
Of the 2,818 blood cultures in this study, only 90 (3.2%) 
had positive cultures for Salmonella species. Of the 90 
isolates, 68 (75.6%) were Salmonella enterica serotype 
typhi, Salmonella paratyphi A, 4 (4.4%), Salmonella 
paratyphi B, 16 (17.8%) and Salmonella paratyphi C, 2 
(2.2%). 
Of the 10,007 faecal samples cultured in this study, only 
159 (1.6%) had positive cultures for Salmonella species. 
Of the 159 isolates, 95 (59.8%) were Salmonella enterica 
serotype typhi, Salmonella paratyphi A, 15 (9.4%), 
Salmonella paratyphi B, 31 (19.5%), Salmonella 
paratyphi C, 10 (6.3%), and Salmonella typhimurium, 8 
(5.0%). 
In this study, the isolation rate of Salmonella enterica 
serotype typhi was higher from blood cultures than 
from faecal cultures (75.6% from blood and 59.8% from 
faeces). The reverse was however the case with the 
other species. Of the Salmonella paratyphi A isolates, 




cultures. Blood cultures had 17.8% of Salmonella 
paratyphi B isolation rate as against the 19.5% from 
faecal cultures. 2.2% of Salmonella paratyphi C were 
recovered from blood cultures as against the 6.3% from 
faecal cultures. We have no explanations why the above 
trend was encountered. However, the isolation of 
Salmonella typhimurium from faecal samples only was 
not surprising. In 2007, it was reported that blood 
cultures are usually negative for Salmonella 
typhimurium, but faecal cultures remain positive for 





The laboratory diagnosis or confirmation of enteric 
fever entails the isolation of the causative (aetiologic) 
agent and the determination of its sensitivity or 
resistance patterns to commonly used antimicrobial 
drugs for proper patient management. 
 
The indiscriminate pretreatment with antibiotics before 
seeking medical attention in our hospitals and 
subsequent actual laboratory diagnosis continues to 
reduce the recovery rate of Salmonellae from our 
patient population. 
 
Most times, the clinician may not wait to carry out 
laboratory test before commencement of treatment. This 
should be seen and viewed as contrary to modern 
medical practice which is ‘’evidence based”. Moreover, 
this impatient attitude by some medical practitioners 
among other negative effects will certainly increase the 
rate of bacterial resistance to commonly used antibiotics.  
 
In conclusion therefore, treatment for enteric fever 
should henceforth be through antibiotics (drugs) 
dispensed at the Pharmacy based on the Clinician’s 
prescription which rely on proper laboratory diagnostic 
result clearly stating the aetiology and susceptible drugs
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